Counterpoint: Big Pharma needs to recognize the drug-cost problem it created
It must look at executive compensation and at big spending on lobbying before asking others to absorb the pain of affordability.
It must look at executive compensation and at big spending on lobbying before asking others to absorb the pain of affordability.